22157.jpg
Major Depressive Disorder: New Insight-Focused Report Forecasts a Landscape Shifting 2019-2029
22. Januar 2024 12:18 ET | Research and Markets
Dublin, Jan. 22, 2024 (GLOBE NEWSWIRE) -- The "Major Depressive Disorder - Eight-Market Drug Forecast and Market Analysis - Update" report has been added to ResearchAndMarkets.com's offering. A...
22157.jpg
Global Major Depressive Disorder (MDD) Drug Market Report 2021: Therapeutics Market Will Grow to $7.9B by 2029
19. April 2021 07:58 ET | Research and Markets
Dublin, April 19, 2021 (GLOBE NEWSWIRE) -- The "Major Depressive Disorder - Global Drug Forecast and Market Analysis to 2029" report has been added to ResearchAndMarkets.com's offering. The MDD...
Cutting Edge Information Analyzes the Bristol-Myers Squibb / Otsuka Pharma Profit-Sharing Strategy for 2010 and Beyond
16. April 2009 10:17 ET | Cutting Edge Information
RESEARCH TRIANGLE PARK, NC--(Marketwire - April 16, 2009) - The recently announced deal between Bristol-Myers Squibb and Otsuka over Abilify will go a long way toward shoring up both companies'...